ASX Earnings

ASX reported its FY2025Q3 earnings on 2025-10-30, showcasing a revenue of 168.57B against an estimate of 162.64B, resulting in a 3.64% surprise. The EPS was 0.16, surpassing the expected 0 by 0%. The stock experienced a 4.23% price change on the earnings day and a 6.51% change over the next five days, reflecting market reactions to the results.

Following ASX's FY2025Q3 earnings announcement on 2025-10-30, the stock price moved by 4.23% on the day of the release. Over the subsequent five days, it saw a 6.51% change. Historically, ASX's stock price tends to shift by an average of 1.99% in the 10 days leading up to earnings and -1.38% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate ASX's annual revenue to reach 161.86B, while the EPS is projected at 0.15. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates revised downward by -0.04% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ASX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved revised downward by -0.04%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ASX's stock price typically moves by 1.99% in the 10 days before its earnings and -1.38% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.15 and revenue of 161.86B.

The earnings call indicates optimism with growth in ATM revenue and gross margins, supported by strong demand and strategic acquisitions like EugenLight. The Q&A section further supports this sentiment with increased LEAP revenue guidance and strategic realignment in the EMS business towards AI opportunities. However, some caution is noted due to management's avoidance of specific long-term guidance and EMS growth timelines. Overall, the positive growth outlook and strategic initiatives suggest a positive stock price movement.